Inflammatory Disorders (Paperback, Softcover reprint of the original 1st ed. 2015)

The mechanistic basis of chronic inflammation remains unclear. The research sheds new light on the immune cells expressing the activation markers HLA-DR and regulatory T cells (Tregs) and the cells expressing Siglec receptors as being key players in the immune system responsiveness to antigens and thus in lung tissue damage of chronic inflammation. The results help understand the mechanisms of action of common drugs used in COPD, such as formoterol, tiotropium, or corticosteroids, and point to novel drug targets. The chapters also deal with brain damaging effects, by far unrecognized, of inhaled corticosteroid therapy, a time-proven management of chronic inflammatory airway conditions; asthma being a case in point. Novel methods, likely less producing side effects, of macrolide antibiotics administration by inhalation are discussed, emphasizing not only bacteriostatic but also anti-inflammatory action.

General

Imprint:	Springer International Publishing AG
Country of origin:	Switzerland
Series:	Neuroscience and Respiration, 839
Release date:	August 2016
First published:	2015
Editors:	Mieczyslaw Pokorski
Dimensions:	254 x 178 x 4mm (L x W x T)
Format:	Paperback
Pages:	67
Edition:	Softcover reprint of the original 1st ed. 2015
ISBN-13:	978-3-319-36372-1
Categories:	Books > Medicine > Clinical & internal medicine > Respiratory medicine Books > Medicine > General issues > Public health & preventive medicine > General Books > Medicine > General issues > Health systems & services > General practice Books > Medicine > Other branches of medicine > Pharmacology > General Promotions
LSN:	3-319-36372-7
Barcode:	9783319363721

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!